Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Definition and Management of Segmental Pulmonary Hypertension..
J Am Heart Assoc. 7(14),
(2018). Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis..
Am J Hematol. 91(5), 499-502.
(2016). Cardiac and renal complications of carfilzomib in patients with multiple myeloma..
Blood Adv. 1(7), 449-454.
(2017). An immunohistochemical study of mechanoreceptors in lumbar spine intervertebral discs..
J Clin Neurosci. 17(6), 742-5.
(2010). Micro- and macrovascular treatment targets in scleroderma heart disease..
Curr Pharm Des. 20(4), 536-44.
(2014). Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets..
Curr Pharm Des. 18(11), 1457-64.
(2012). Neuropathic pain in osteoarthritis: a review of pathophysiological mechanisms and implications for treatment..
Semin Arthritis Rheum. 44(2), 145-54.
(2014). Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors..
Clin Rheumatol. 32(9), 1357-64.
(2013). Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study..
Rheumatol Int. 31(2), 263-7.
(2011). Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation..
Arthritis Res Ther. 19(1), 32.
(2017). Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis..
Clin Rheumatol. 29(9), 957-64.
(2010). Scleroderma renal crisis accompanied by new-onset pulmonary arterial hypertension: an acute systemic endothelial injury? Case report and literature..
Inflamm Allergy Drug Targets. 9(4), 313-8.
(2010). Lack of association between polymorphisms of thrombogenic genes and disease susceptibility in rheumatoid arthritis..
Rheumatol Int. 33(9), 2429-32.
(2013). Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis..
Curr Med Chem. 22(16), 1943-55.
(2015). Genetic variations in the alanine-glyoxylate aminotransferase 2 (AGXT2) gene and dimethylarginines levels in rheumatoid arthritis..
Amino Acids. 49(6), 1133-1141.
(2017). Biomarkers in systemic sclerosis-related pulmonary arterial hypertension..
Curr Vasc Pharmacol. 9(2), 213-9.
(2011). Biologic drugs as analgesics for the management of osteoarthritis..
Semin Arthritis Rheum. 46(6), 687-691.
(2017). Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis..
Int J Cardiol. 172(1), 285-6.
(2014). Symmetric Dimethylarginine Is Not Associated with Cumulative Inflammatory Load or Classical Cardiovascular Risk Factors in Rheumatoid Arthritis: A 6-Year Follow-Up Study..
Mediators Inflamm. 2015, 796562.
(2015). Clinical outcome of ultrasound-guided steroid injections for chronic shoulder pain..
Int J Rheum Dis. 16(4), 398-402.
(2013). Natriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension..
Semin Arthritis Rheum. 39(4), 278-84.
(2010). Biologic therapies and systemic bone loss in rheumatoid arthritis..
Autoimmun Rev. 12(10), 958-66.
(2013). Symmetric dimethylarginine (SDMA) serum levels in rheumatoid arthritis: correlations with insulin resistance and disease activity scores..
Amino Acids. 47(9), 1995-2004.
(2015).
(2014).
(2010).